Screen LibraryCancer biomarkers : minimal and noninvasive early diagnosis and prognosis /
"According to the American Cancer Society report, "by 2030, the global cancer burden is expected to nearly double, growing to 21.4 million cases and 13.2 million deaths." Early diagnosis improves treatment efficacy and quality of life as well as reduces the cost for disease management...
Saved in:
| Group Author: | ; ; ; |
|---|---|
| Published: |
CRC Press, Taylor & Francis Group,
|
| Publisher Address: | Boca Raton : |
| Publication Dates: | [2014] |
| Literature type: | Book |
| Language: | English |
| Subjects: | |
| Summary: |
"According to the American Cancer Society report, "by 2030, the global cancer burden is expected to nearly double, growing to 21.4 million cases and 13.2 million deaths." Early diagnosis improves treatment efficacy and quality of life as well as reduces the cost for disease management. However, the development of molecular markers for early cancer diagnosis is always a challenge. Some fundamental principles in medical practice are (a) primum non nocere, a Latin phrase that means "first, do no harm," and (b) even when a patient's prognosis is poor, the physician must do his or her best for im |
| Carrier Form: | xxiii, 949 pages : illustrations (some color) ; 26 cm |
| Bibliography: | Includes bibliographical references and index. |
| ISBN: |
9781466584280 : 1466584289 |
| Index Number: | RC270 |
| CLC: | R730.4 |
| Call Number: | R730.4/C215-4 |